2023 Lupus Research Alliance Breaking Through Gala
Join Us for the 2023 Lupus Research Alliance Breaking Through Gala
REGISTER NOW ►
</di
Stories & News
Where There’s a Will, There’s a Way to Leave Your Mark
August is National “Make-a-Will-Month” -- the time when we are reminded of the importance of thinking ahead to leave...
LRA Mourns Loss of Dear Friend Tony Bennett
July 25, 2023
The Lupus Research Alliance extends heartfelt condolences to the wife, Susan, and children of our former honorary...
Data Shows Voclosporin Preserves Kidney Function for Three Years
July 19,2023
The LRA is pleased to share news announced by Aurinia Pharmaceuticals of published results showing that the lupus...
Analysis Found Rituximab Biosimilar Showed Effectiveness in Treating Pediatric Lupus Nephritis
Rituximab biosimilar BCD020 showed effectiveness in treating lupus nephritis in a pediatric population according to results of a retrospective...
Thank You for Making a Difference During Lupus Awareness Month
June 1, 2023
What a month May was! As we reflect upon Lupus Awareness month, the community continues to inspire. ...
EULAR Presentation Showed Upadacitinib Improved Lupus Disease Activity
May 31, 2023
We are pleased to share encouraging news from EULAR, the annual meeting of the European Alliance of...
Overview of Lupus ABC Inaugural Meeting April 16-17, 2023
The Lupus Research Alliance is pleased to report that the Lupus Accelerating Breakthroughs Consortium (Lupus ABC) held its inaugural...
Investigational CAR T Cell Gets Fast Tracked by U.S. FDA
May 1, 2023
The LRA and our clinical arm Lupus Therapeutics are pleased to share good news from Cabaletta Bio,...
ManyOne ARE Making the Difference
May 1, 2023
Last year, the Lupus Research Alliance launched our ManyOne Can campaign during Lupus Awareness Month to offer...
Ten Tips During Stress Awareness Month and Beyond
April, 2023
Tips to Lower Stress During Stress Awareness Month and Beyond
If you are a person with lupus and often...
Rinvoq Advances to Phase 3 in Lupus
March 27, 2023
Based on positive results of a Phase 2 clinical trial testing upadacitinib (Rinvoq®) given alone or with...